What is a healthcare and life sciences expert network?

A Nextyn healthcare and life sciences expert network connects decision makers with clinicians, payers, regulatory specialists and former commercial leads across 70+ countries. Conversations establish how a therapy, device or service is actually adopted and paid for, which are separate questions with separate answers: clinical preference does not determine access, and formulary position does not determine prescribing. Coverage spans pharma, biotech, medical devices, diagnostics, providers and payers. Every expert is screened against exclusion and debarment lists before a call is booked.

Who do you reach on the payer side?

Nextyn reaches former medical directors, pharmacy and therapeutics committee members, formulary and benefit design leads at commercial insurers and pharmacy benefit managers, and public payer officials. Payer structures are country-specific, so Nextyn recruits against the specific market in the brief, reaching the commercial, public and technology-assessment seats that decide access in whichever system applies. Conversations cover formulary placement, prior authorisation and step therapy, tender dynamics and what evidence actually moved a coverage decision.

How do you test whether a clinician will switch?

Nextyn tests switching intent by asking prescribers who treat the relevant population what would have to be true for them to change. Three things determine the answer: the evidence they would need to see and at what threshold, the access barrier they face on formulary or prior authorisation, and what the switch costs them in workflow. The third is routinely underweighted in commercial models and is frequently the binding constraint. Nextyn recruits prescribers by specialty, setting and patient volume rather than by title, and briefs them that patient-identifiable information and off-label discussion are out of scope.

Do you cover devices and diagnostics as well as pharma?

Yes. Nextyn covers medical devices and diagnostics alongside pharma, biotech, providers and payers. Device and diagnostic adoption runs through a different process from pharma, and Nextyn recruits for it accordingly: hospital value analysis committee members, procurement and supply chain leads, biomedical engineering staff, proceduralists and lab directors. Conversations cover capital versus consumable economics, GPO and tender position, reimbursement coding, and what a value analysis committee actually requires before approving a switch. Diagnostics briefs additionally reach lab directors and reference lab commercial leads.

How do you keep healthcare expert calls compliant?

Nextyn screens every healthcare expert against exclusion and debarment lists before a call is booked. Screening also covers current employment, confidentiality obligations, and independence against every company in scope. Experts are briefed that patient-identifiable information, off-label promotion and any unpublished trial data are out of scope, and that material non-public information about a listed company stays with them. Every transcript is scanned before delivery.

How soon can I speak to an expert?

Nextyn schedules most first calls within 24 to 48 hours of the brief. That timeframe is inside the window most life sciences commercial diligence processes allow before an investment committee date. A senior operator in a narrow segment takes longer to source than a category specialist, and where a brief falls into that category Nextyn says so upfront and commits to a date it can hold. A research lead returns angles, candidate names and rates before anything is booked, and no call is scheduled until the client approves the expert.

Which regions do you cover?

Nextyn sources experts globally, across 70+ countries, with in-market researchers supporting every region it covers. A brief in any covered market is handled by researchers who know that market, which extends reach past listed corporates into distributors, dealers and independent operators. References can be taken in the expert’s own market and language, which allows one brief to run consistently across several geographies at once. Nextyn confirms coverage for the specific markets in a brief at the outset, so a client knows the reach before the engagement begins.

How does Nextyn’s pricing model work?

Nextyn confirms the cost of an engagement in writing before any expert is approached. A research lead returns candidate names and their rates within 24 to 48 hours of the brief, so a client sees the real cost of the experts actually proposed before committing. Cost reflects the seniority of the experts involved and the number of conversations a question needs, scoped against each brief. A client can start with a single project. Teams running continuous research move to a credit arrangement sized to expected usage.

The expert network for healthcare & life sciences intelligence

Former prescribers, payer executives, commercial leads and regulatory specialists across pharma, biotech, devices, diagnostics, providers and payers. Matched to your question.

Start a project

Consulting case teamBiologics contract manufacturingA case team was sizing biologics contract manufacturing around a capacity constraint. We put the plant side and the sponsor side in the same session.
Read more

Private equity deal teamHealthcare and life sciencesA deal team wanted its committee to be able to test the reasoning. We rebuilt the diligence so every claim traced to a named seat and disagreement was kept.
Read more

Definition

What is a healthcare or life sciences expert?

A healthcare and life sciences expert is a clinician, payer, former commercial lead or regulatory specialist who can speak first hand to how a therapy, device or service is adopted and paid for. Nextyn sources them across pharma, biotech, medical devices, diagnostics, providers and payers.

Brief to expertmatched against the question you are asking

5 sub-sectorspharma to payers

Prescribers & payersthe two assumptions that break first

The sector

Every sub-sector answers to a different buyer.

01
Pharmaceuticals and biotech
Formulary position and the rebate that holds it, the switch dynamics sitting under a share curve, how trial data reads across into real-world use, and what a launch actually achieves once the payer, the prescriber and the pharmacy have each had their say.
02
Medical devices and equipment
Surgeon preference and the switching cost buried in the service contract, tender and GPO terms, capital against consumable economics across the installed base, and how long a clinical champion holds an account once the rep changes.
03
Diagnostics and lab services
Reimbursement per test and the coding that sets it, placement economics across central lab, point of care and molecular, pull-through from the ordering clinician, and how quickly a menu addition earns back the instrument it sits on.
04
Providers and care delivery
Case mix, throughput and cost per episode, the referral pattern that fills a site, payer contracting from the provider side of the table, and what a network actually does with a protocol once it has been signed centrally.
05
Payers and access
Coverage decisions and prior authorization as they are applied in practice, the evidence a committee needs before it moves, rebate and tier negotiation, and where a forecast quietly breaks between list price and net.

How we support you

One call, or the whole year.

Speak to expertsExpert callsOne former prescriber, payer executive or commercial lead.Moderated callsWe run the interview and send you the output.AI-moderated callsYour discussion guide, put to clinicians and payers at volume.Multi-expert panelsA prescriber, a payer and a commercial lead on one question.Field immersionsHospital, clinic and lab visits, run compliantly.Workshops and round tablesA convened session on a live therapy area or access question.Opinion surveysCounted across prescribers, payers and procurement committees.

Longer engagementsAdvisory boardsA standing bench of former clinicians and payer executives.Long-term consulting supportAn embedded consultant for the length of a project.Interim and fractional executivesAn operator placed into the business while you hire.Executive and board searchRetained hiring for medical, commercial and regulatory roles.Expert witness and litigationTestifying and consulting experts on technical and clinical disputes.

Capabilities

What we can find out, and who from.

What a payer and a prescriber can tell you before a launch plan is committed.

Why Nextyn

Depth, reach, speed, and a compliance file.

Sector depth former prescribers, payer executives and commercial leads, matched to the therapy area or device class
Regional edge India, Southeast Asia and the Gulf, with full reach across North America and Europe
Pace experts matched while the question is still live
Healthcare compliance no patient data, no off-label discussion, and every transcript screened before delivery

Expertise in action

The work, when we can name it.

Case studies and writing from this sector.

Case studyPayer Contracting Round Table Case StudyA round table workshop with former payer and market access leads on coverage decisionsRead more

Case studyPharmaceutical Formulation Expert Sourcing Case StudySourcing and screening for conflicts first, then for plain explanation of the scienceRead more

ArticleWhat Payers Say Before They SignPayer coverage decisions turn on budget impact and comparator choice more than on clinical data. How to test a reimbursement assumption early.Read more

ArticleTesting Prescriber Switching IntentStated switching intent overstates real switching by a predictable margin. How to ask the question so the answer means something.Read more

Start here

Speak to an expert about your question

A dedicated Client Solutions Manager will be in touch shortly to help with your research needs.

Start a project

01
Send your project scope
Your questions, and the thesis behind them. A paragraph of context is enough.
02
We come back with angles and expert profiles
A shortlist with rates included.
03
Approve, then we field
You select and approve the experts you want to speak to.
04
Nextyn IQ reads across the whole project
Agreement, contradictions and open gaps, read across every call in the project.

Request experts

Tell us about your research needs

Start with a single project. We shape the commercial terms around how you want to work.

The expert network for healthcare & life sciences intelligence

What is a healthcare or life sciences expert?

Every sub-sector answers to a different buyer.

Pharmaceuticals and biotech

Medical devices and equipment

Diagnostics and lab services

Providers and care delivery

Payers and access